Exploring the ‘RPRL’ Motif of Apelin-13 through Molecular Simulation and Biological Evaluation of Cyclic Peptide Analogues

ChemMedChem ◽  
2010 ◽  
Vol 5 (8) ◽  
pp. 1247-1253 ◽  
Author(s):  
N. J. Maximilian Macaluso ◽  
Robert C. Glen
2011 ◽  
Vol 19 (24) ◽  
pp. 7526-7533 ◽  
Author(s):  
María Isabel García-Aranda ◽  
Yasmina Mirassou ◽  
Benoit Gautier ◽  
Mercedes Martín-Martínez ◽  
Nicolas Inguimbert ◽  
...  

2018 ◽  
Vol 8 (12) ◽  
pp. 213 ◽  
Author(s):  
George Deraos ◽  
Eftichia Kritsi ◽  
Minos-Timotheos Matsoukas ◽  
Konstantina Christopoulou ◽  
Hubert Kalbacher ◽  
...  

Background: Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system. MS is a T cell-mediated disease characterized by the proliferation, infiltration, and attack of the myelin sheath by immune cells. Previous studies have shown that cyclization provides molecules with strict conformation that could modulate the immune system. Methods: In this study, we synthesized peptide analogues derived from the myelin basic protein (MBP)82–98 encephalitogenic sequence (dirucotide), the linear altered peptide ligand MBP82–98 (Ala91), and their cyclic counterparts. Results: The synthesized peptides were evaluated for their binding to human leukocyte antigen (HLA)-DR2 and HLA-DR4 alleles, with cyclic MBP82–98 being a strong binder with the HLA-DR2 allele and having lower affinity binding to the HLA-DR4 allele. In a further step, conformational analyses were performed using NMR spectroscopy in solution to describe the conformational space occupied by the functional amino acids of both linear and cyclic peptide analogues. This structural data, in combination with crystallographic data, were used to study the molecular basis of their interaction with HLA-DR2 and HLA-DR4 alleles. Conclusion: The cyclic and APL analogues of dirucotide are promising leads that should be further evaluated for their ability to alter T cell responses for therapeutic benefit against MS.


2020 ◽  
Vol 105 ◽  
pp. 104391
Author(s):  
Wei-Ya Li ◽  
Ying Ma ◽  
Hao-Xin Li ◽  
Xin-Hua Lu ◽  
Shan Du ◽  
...  

ChemInform ◽  
2010 ◽  
Vol 31 (21) ◽  
pp. no-no
Author(s):  
Stefan Menzler ◽  
Jack A. Bikker ◽  
Nirmala Suman-Chauhan ◽  
David C. Horwell

1993 ◽  
Vol 680 (1 The Melanotro) ◽  
pp. 517-519
Author(s):  
GEORGE FORSYTH ◽  
SARAH BRANCH ◽  
STEPHEN MOSS ◽  
LIDIA NOTARIANNI ◽  
DAVID OSGUTHORPE ◽  
...  

2009 ◽  
Vol 19 (12) ◽  
pp. 3220-3224 ◽  
Author(s):  
Hiroyuki Nakamura ◽  
Mizuyoshi Watanabe ◽  
Hyun Seung Ban ◽  
Wataru Nabeyama ◽  
Akira Asai

2017 ◽  
Vol 350 (10) ◽  
pp. 1700158 ◽  
Author(s):  
Mohammad A. Ahmaditaba ◽  
Soraya Shahosseini ◽  
Bahram Daraei ◽  
Afshin Zarghi ◽  
Mohammad H. Houshdar Tehrani

2005 ◽  
Vol 83 (6-7) ◽  
pp. 875-881 ◽  
Author(s):  
Amanda N Whelan ◽  
Jomana Elaridi ◽  
Roger J Mulder ◽  
Andrea J Robinson ◽  
W Roy Jackson

Dicarba cyclic peptide analogues of the cystine-containing octapeptides octreotide, lanreotide, and vapreotide, all known somatostatin analogues, have been synthesized via an on-resin homogeneous metal-catalysed sequence involving ruthenium-catalysed ring-closing metathesis followed by rhodium-catalysed hydrogenation.Key words: dicarba-analogues of cystine-containing peptides, octreotide, vapreotide, and lanreotide; tandem ring-closing metathesis and hydrogenation.


Sign in / Sign up

Export Citation Format

Share Document